BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21773075)

  • 1. Potential of soluble CD26 as a serum marker for colorectal cancer detection.
    Cordero OJ; Imbernon M; Chiara LD; Martinez-Zorzano VS; Ayude D; de la Cadena MP; Rodriguez-Berrocal FJ
    World J Clin Oncol; 2011 Jun; 2(6):245-61. PubMed ID: 21773075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context.
    De Chiara L; Páez de la Cadena M; Rodríguez-Berrocal J; Alvarez-Pardiñas MC; Pardiñas-Añón MC; Varela-Calviño R; Cordero OJ
    Dis Markers; 2020; 2020():4347936. PubMed ID: 32051696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas.
    De Chiara L; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Cordero OJ; Martínez-Ares D; Páez de la Cadena M
    BMC Cancer; 2010 Jun; 10():333. PubMed ID: 20584285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of serum dipeptidyl peptidase (DPP- IV) /CD26 as a serum marker in Egyptian patients with colorectal cancer.
    Elzefzafy WM; Abd Elrahman S; Mohmmed ZA; Atef N
    J Immunoassay Immunochem; 2020 Jul; 41(4):729-744. PubMed ID: 32223519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the origin of serum CD26 and its altered concentration in cancer patients.
    Cordero OJ; Salgado FJ; Nogueira M
    Cancer Immunol Immunother; 2009 Nov; 58(11):1723-47. PubMed ID: 19557413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.
    Otero-Estévez O; De Chiara L; Rodríguez-Berrocal FJ; Páez de la Cadena M; Cubiella J; Castro I; Gonzalez-Mao C; Hernandez V; Martínez-Zorzano VS
    Br J Cancer; 2015 Jan; 112(2):375-81. PubMed ID: 25461801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
    Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
    Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
    Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
    J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs.
    De Chiara L; Barcia-Castro L; Gallardo-Gómez M; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Cubiella J; Cordero OJ
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.
    Cordero OJ; Ayude D; Nogueira M; Rodriguez-Berrocal FJ; de la Cadena MP
    Br J Cancer; 2000 Nov; 83(9):1139-46. PubMed ID: 11027426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two commercial ELISAs against an in-house ELISA for measuring soluble CD26 in human serum.
    Ohnuma K; Saito T; Hatano R; Hosono O; Iwata S; Dang NH; Ninomiya H; Morimoto C
    J Clin Lab Anal; 2015 Mar; 29(2):106-11. PubMed ID: 24687574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum level of soluble CD26/dipeptidyl peptidase 4 increases in response to acute hyperglycemia after an oral glucose load in healthy subjects: association with high-molecular weight adiponectin and hepatic enzymes.
    Aso Y; Terasawa T; Kato K; Jojima T; Suzuki K; Iijima T; Kawagoe Y; Mikami S; Kubota Y; Inukai T; Kasai K
    Transl Res; 2013 Nov; 162(5):309-16. PubMed ID: 23994650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.
    Tao S; Haug U; Kuhn K; Brenner H
    Br J Cancer; 2012 Apr; 106(8):1424-30. PubMed ID: 22454079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interest.
    Cordero OJ; Varela-Calviño R; López-González T; Grujic M; Juranic Z; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; de la Iglesia BA; Pego-Reigosa JM
    Clin Biochem; 2017 Nov; 50(16-17):903-910. PubMed ID: 28599787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.
    Cordero OJ; Varela-Calviño R; López-González T; Calviño-Sampedro C; Viñuela JE; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; Aspe de la Iglesia B; Pego-Reigosa JM
    PLoS One; 2015; 10(7):e0131992. PubMed ID: 26177310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD26 levels and its association to epidemiologic parameters in a sample population.
    De Chiara L; Rodríguez-Piñeiro AM; Cordero OJ; Rodríguez-Berrocal FJ; Ayude D; Rivas-Hervada And FJ; de la Cadena MP
    Dis Markers; 2009; 27(6):311-6. PubMed ID: 20075514
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.